The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

In re NII Holdings
Represented creditors committee for NII Holdings Inc. (f.k.a. Nextel International) in connection with restructuring of more than $2 more
Patent licensing and research transactions for a medical research foundation
Represented a medical research foundation in patent licensing and sponsored research transactions since 1989.  The medical technology has spanned more
In-fill real estate projects representation of developer
Represented developer in various in-fill real estate projects in Raleigh, North Carolina, including acquisition, redevelopment and structuring more
Environmental issues advice for a Canadian pulp and paper company
Representation of a Canadian pulp and paper company regarding a variety of environmental issues including compliance requirements under federal and more